Suppr超能文献

DNA疫苗诱导的CD8+ T淋巴细胞表位免疫显性等级的调控

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.

作者信息

Liu Jinyan, Ewald Bonnie A, Lynch Diana M, Nanda Anjali, Sumida Shawn M, Barouch Dan H

机构信息

Research East Room 213, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.

出版信息

J Virol. 2006 Dec;80(24):11991-7. doi: 10.1128/JVI.01348-06. Epub 2006 Sep 27.

Abstract

Generating broad cellular immune responses against a diversity of viral epitopes is a major goal of current vaccine strategies for human immunodeficiency virus type 1 (HIV-1) and other pathogens. Virus-specific CD8(+) T-lymphocyte responses, however, are often highly focused on a very limited number of immunodominant epitopes. For an HIV-1 vaccine, the breadth of CD8(+) T-lymphocyte responses may prove to be critical as a result of the need to cover a wide diversity of viral isolates in the population and to limit viral escape from dominant epitope-specific T lymphocytes. Here we show that epitope modification strategies can alter CD8(+) T-lymphocyte epitope immunodominance hierarchies elicited by a DNA vaccine in mice. Mice immunized with a DNA vaccine expressing simian immunodeficiency virus Gag lacking the dominant D(b)-restricted AL11 epitope generated a marked and durable augmentation of responses specific for the subdominant D(b)-restricted KV9 epitope. Moreover, anatomic separation strategies and heterologous prime-boost regimens generated codominant responses against both epitopes. These data demonstrate that dominant epitopes can dramatically suppress the immunogenicity of subdominant epitopes in the context of gene-based vaccines and that epitope modification strategies can be utilized to enhance responses to subdominant epitopes.

摘要

产生针对多种病毒表位的广泛细胞免疫反应是目前针对人类免疫缺陷病毒1型(HIV-1)和其他病原体的疫苗策略的主要目标。然而,病毒特异性CD8(+) T淋巴细胞反应通常高度集中于极少数免疫显性表位。对于HIV-1疫苗而言,由于需要覆盖人群中广泛多样的病毒分离株并限制病毒从显性表位特异性T淋巴细胞中逃逸,CD8(+) T淋巴细胞反应的广度可能至关重要。在此我们表明,表位修饰策略可改变DNA疫苗在小鼠中引发的CD8(+) T淋巴细胞表位免疫显性等级。用表达缺乏显性D(b)限制性AL11表位的猿猴免疫缺陷病毒Gag的DNA疫苗免疫的小鼠,对次显性D(b)限制性KV9表位产生的反应显著且持久增强。此外,解剖学分离策略和异源初免-加强方案产生了针对这两种表位的共显性反应。这些数据表明,在基于基因的疫苗背景下,显性表位可显著抑制次显性表位的免疫原性,且表位修饰策略可用于增强对次显性表位的反应。

相似文献

引用本文的文献

4
Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.新型恒河猴腺病毒疫苗载体的快速克隆
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.01924-17. Print 2018 Mar 15.
10
HIV DNA Vaccine: Stepwise Improvements Make a Difference.HIV DNA疫苗:逐步改进产生显著效果。
Vaccines (Basel). 2014 May 14;2(2):354-79. doi: 10.3390/vaccines2020354.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验